You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OKUR Award Disclosure
Leverone Jason A. · SEC Form 4 · Filed Aug 11, 2026
Award
Reported value range
Not reported
Leverone Jason A. Chief Financial Officer
OKUR
Transaction date
Aug 7, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 4 days later
OKUR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Class A Common Stock
- Quantity / price
- 130,611 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001692747-26-000004
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | $0 |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Award | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR | Disposition | Aug 7, 2026 | Not reported |
| Onkure Therapeutics, Inc. OKUR Current | Award | Aug 7, 2026 | Not reported |